Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease
Oncoscience · 12.07.2014 · 1 (7) · 486-503
DOI: 10.18632/oncoscience.64 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncoscience, erschienen am 12.07.2014. Verfasst von Tim N Beck und 3 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA ; Program in Molecular and Cell Biology and Genetics, Drexel Unive…. Die Arbeit wurde bisher 47-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA ; Program in Molecular and Cell Biology and Genetics, Drexel University College of Medicine, Philadelphia, PA, USA.
- Developmental Therapeutics Program, Fox Chase Cancer Center, Philadelphia, PA, USA.
Förderung
- NCI NIH HHS
Zitieren
APA
Beck, T. N., Nicolas, E., Kopp, M. C., & Golemis, E. A. (2014). Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease. Oncoscience, 1(7), 486-503. https://doi.org/10.18632/oncoscience.64
Vancouver
Beck TN, Nicolas E, Kopp MC, Golemis EA. Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease. Oncoscience. 2014;1(7):486-503. doi:10.18632/oncoscience.64
BibTeX
@article{Beck2014,
author = {Beck, Tim N and Nicolas, Emmanuelle and Kopp, Meghan C and Golemis, Erica A},
title = {Adaptors for disorders of the brain? The cancer signaling proteins NEDD9, CASS4, and PTK2B in Alzheimer’s disease},
journal = {Oncoscience},
year = {2014},
volume = {1},
number = {7},
pages = {486--503},
doi = {10.18632/oncoscience.64}
}
EUVIMED